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Introduction: We examined the positive predictive value of diagnoses of acute exacerbation of
chronic obstructive pulmonary disease (COPD) in the Danish National Patient Registry. We also
examined the negative predictive value of acute pneumonia or respiratory failure discharge
diagnoses for absence of underlying COPD.
Methods: We identified all patients aged 30 years or older with acute hospital admission in
Denmark from January 1st to December 31st 2008. Physicians at 34 Danish hospitals retrieved
and reviewed medical records for 1581 patients with a discharge diagnosis of COPD, and for
1546 patients with a discharge diagnosis of either pneumonia or respiratory failure but no
COPD diagnosis. Presence of COPD was assessed based on medical history, clinical symptoms
and findings, and spirometry results.
Results: The overall positive predictive value for COPD was 92% (95% confidence interval [CI]
Z 91e93%). Among patients coded with pneumonia or respiratory failure but not COPD, 19%
(95% CIZ 17e21%) had COPD, corresponding to a negative predictive value for COPD of 81%
(95% CIZ 79e83%).
Conclusions: The positive predictive value of acute COPD discharge diagnoses in the Danish
National Patient Registry is high. At the same time, there is a substantial underrecording of
COPD during hospitalizations with other acute respiratory disorders like pneumonia and respi-
ratory failure.
ª 2011 Elsevier Ltd. All rights reserved.of Clinical Epidemiology, Aarhus University Hospital, Sdr. Skovvej 15, DK-9000 Aalborg, Denmark.
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1064 R.W. Thomsen et al.Introduction charge of the patient admission. Diagnosis coding has beenCOPD is a major cause of morbidity and the fourth leading
cause of death in the world.1 In Denmark with a population
of 5.4 million, approximately 10% of persons aged 45 or
older have COPD2,3 and the disease is the cause of
approximately 25,000 hospitalizations every year.4
Use of administrative health care data could be a valu-
able and cost-efficient method of collecting data on COPD,
both for health care quality monitoring and for epidemio-
logical research.5 Administrative registries have the
advantage of readily available data, and high completeness
of registration of patients in the target population.6e8
However, the quality of routinely collected data for
administrative purposes may be questionable for use in
research and in quality measurements, and validation
studies are a prerequisite for using registry-based data for
these purposes.9,10 Although one Danish study has sug-
gested that COPD is often under-diagnosed in patients
admitted to hospital with acute respiratory conditions,11 in
general there is a lack of data on the validity and
completeness of COPD diagnosis in acute patient admis-
sions. In the present nationwide prospective validation
study, we examined the positive predictive value (PPV) of
acute COPD discharge diagnoses for presence of underlying
COPD in the Danish National Patient Registry (DNPR). We
also examined the negative predictive value (NPV) of acute
pneumonia or respiratory failure discharge diagnoses for
absence of COPD.
Methods
This prospective nationwide validation study was con-
ducted as a part of the Danish National Indicator Project
(DNIP). The DNIP started in 2000 and is a nationwide
initiative to document, monitor and improve the quality of
treatment and care provided by the Danish health care
system.12 There is mandatory participation for all Danish
hospitals in DNIP. COPD is one of currently 10 specific
diseases monitored in the DNIP by clinical indicators and
quality standards (see: http://www.nip.dk/
aboutþtheþdanishþnationalþindicatorþproject). COPD
was included in 2008 as the first monitored disease in the
DNIP for which patient data are collected exclusively
through administrative diagnosis codes and codes for
medical procedures in the Danish DNPR, rather than
through primary data collection into a separate quality
database. Therefore, it was decided to validate a large
nationwide sample of COPD codes in the DNPR.
The Danish National Patient Registry (DNPR)
The DNPR covers all individuals within the entire Danish
population of 5.4 million who have been in contact with any
Danish hospital. The Registry has tracked 99.4% of
discharges from all Danish acute-care, non-psychiatric
hospitals since 1977 and all hospital outpatient and emer-
gency department visits since 1995.13 Records include
patients’ unique civil registration numbers, admitting
hospital and department, dates of admission and discharge,
and up to 20 discharge diagnoses coded by physicians inclassified according to the International Classification of
Diseases, 10th revision (ICD-10) since 1994.
Identification of patients coded with COPD,
pneumonia, and respiratory failure in the DNPR
The present study covered all 34 hospitals in Denmark who
reported to care for patients with acute COPD exacerba-
tions in the beginning of 2008. Eligible were all patients
who had a discharge date in the DNPR during the 12-month
period from January 1st through December 31st, 2008.
For the study of the PPV of COPD diagnosis, we retrieved
all acute hospitalization episodes with an ICD-10 hospital
discharge diagnosis code of COPD (J44) among patients
aged 30 years or older (nZ 19,672 patients with COPD)
(group 1). We included COPD diagnoses that were coded
either as primary (first-listed) diagnosis or as a secondary
diagnosis combined with a primary diagnosis code for acute
respiratory failure (J96) or pneumonia (J13eJ18) during the
same hospitalization.
To obtain an estimate of the NPV of absence of any COPD
diagnosis among patients hospitalized with related acute
respiratory disorders, we retrieved all acute hospitalization
episodes with a primary ICD-10 hospital discharge diagnosis
code for either acute respiratory failure (J96) or pneumonia
(J13eJ18) without presence of any diagnosis code of COPD
(J44) during the same hospitalization episode (nZ 1713
patients with respiratory failure and nZ 16,944 patients
with pneumonia) (group 2).
Hospital record review
From the DNPR, we selected for each involved hospital
a random sample of up to 60 acute COPD patient admissions
from group 1, and up to 60 acute non-COPD patient
admissions from group 2 (up to 15 admissions per quarter of
the year 2008, if available, were randomly selected). In this
manner, the total validation cohort included approximately
10% of all patients acutely admitted with COPD diagnosis
during the study period (nZ 1988), and a random sample of
approximately 10% of all patients acutely admitted with
a diagnosis of respiratory failure or pneumonia without any
diagnosis of COPD (nZ 1986). We then sent standardized
registration forms to all involved hospitals, containing the
up to 120 selected patients’ civil registration numbers,
diagnosis codes, and discharge dates, and asked for a clin-
ical audit of the patients’ hospital records. Hospital records
were retrieved and reviewed by senior physicians at the
involved pulmonary and general medical departments. The
review was based on all the available information from
actual and previous hospitalizations in the medical records,
including spirometry results in stable condition, case notes,
radiology reports, and results from laboratory tests. A
diagnosis of COPD was made by the reviewing physician
based on clinical judgment, i.e. when the patient’s medical
history and typical clinical symptoms and signs were in
agreement with COPD, supported by findings from spirom-
etry within the last three years if available in the hospital
record (proportion of the forced vital capacity exhaled in
the first second (FEV1/FVC ratio)< 70%).
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The data validity of COPD diagnosis, expressed as the
positive predictive value (PPV) of the COPD discharge
diagnosis, was calculated as a proportion (i.e., the
numerator containing the number of patients with
confirmed COPD diagnoses after review of medical records,
and the denominator containing the total number of
patients registered with COPD diagnosis). The data validity
of absence of COPD, expressed as the negative predictive
value (NPV) for presence of COPD in cases coded with
pneumonia or respiratory failure (without mentioning
COPD), was also calculated as a proportion (i.e., the
numerator containing the number of patients without COPD
diagnoses after review of medical records, and the
denominator containing the total number of patients
registered with pneumonia or respiratory failure (without
COPD diagnoses)). Furthermore, data were stratified based
on gender, administrative region in Denmark, and type of
admitting hospital department (specialized pulmonary
medicine versus general medicine; only 2% of patients had
been admitted to non-medical departments). PPVs were
also calculated separately for COPD as primary (first-listed)
and secondary diagnosis, and restricted to COPD confirmed
by spirometry with FEV1/FVC ratio< 70% within the last 3
years according to available data in hospital records. NPVs
for absence of COPD were calculated separately for diag-
noses of pneumonia and respiratory failure. To estimate
95% confidence intervals (CI) and compare proportions, an
approximation to the binomial distribution was assumed.
Results
Descriptive data
Table 1 shows characteristics of the 19,672 patients acutely
admitted with COPD diagnosis in Denmark and recorded in
the DNIP database in 2008 who were eligible for sampling for
this validation study, as well as the sampled validation group
of 1988 COPDpatients. Therewere slightlymorewomen than
men, and half of the cohort was older than 74 years. More
than half of the patients had previously hospital-diagnosed
comorbidity other thanCOPDas evidenced from theCharlson
comorbidity index7,8 prior to admission. The cumulative
30-day mortality after acute COPD admission was 9e10%.
Table 1 also shows characteristics of the sampled validation
group of 1986 patients admitted with pneumonia or respira-
tory failurewithout COPD diagnosis. Comparedwith patients
diagnosedwithCOPD, thesepatientswereof comparable age
(median 75 years), slightly more were men (52%), and less
had comorbidity recorded.
Validation of COPD
Among the nationwide subgroup of 1988 patients with a COPD
discharge diagnosis randomly sampled for the validation
study, physicians at the involved hospitals retrieved and
reviewed hospital records and returned the filled data forms
for 1581 hospitalization episodes (80%). The primary reasons
for not returning filled data forms were logistic difficulties
and/or lack of human resources at a number of hospitals, whotherefore did not participate in the validation study (a
nationwidenurses’strike tookplace inDenmarkbetweenApril
16 and June 15, 2008). Among the 1581 validated patient
episodes, the overall PPV for COPD was 92% (95% confidence
interval [CI] 91e93%) (Table 2). Stratification by gender
revealedaPPVof92%(90e94%) inbothmenandwomen.When
we stratified the data by the five administrative regions of
Denmark, the PPVs for COPD were uniformly high, ranging
from 87% to 94%. The PPV for COPD among episodes with
a primary (first-listed) COPD diagnosis was 93% (95% CI
92e95%), whereas the PPV for COPD in episodes with
a secondary COPD diagnosis combined with a primary diag-
nosis of acute respiratory failure or pneumonia was slightly
lower at 87% (95% CI 84e91%). When we stratified the data on
the type of admitting hospital department, the PPV for COPD
was 95% (92e97%) in the specialized pulmonary medical
departments and 92% (90e93%) in the general medical
departments. The PPV for COPD reported to be confirmed by
spirometry (FEV1/FVC ratio< 70%) based on availability of
data in hospital records within the last 3 years was substan-
tially lowerat61% (95%CI59e64%)overall and75% (70e80%) in
the specialized pulmonary medical departments.
Validation of absence of COPD
Among the nationwide sampled subgroup of 1986 patients
who had been discharged with a diagnosis of respiratory
failure or pneumonia without any mention of COPD,
physicians retrieved and reviewed hospital record and
returned filled data forms for 1546 hospitalization episodes
(78%). Reasons for non-participation of hospitals were the
same as for the patients with COPD diagnoses mentioned
above. In this subgroup, 19% (95% CI 17e21%) had COPD,
corresponding to a NPV for COPD of 81% (95% CI 79e83%)
(Table 3). Stratification on gender revealed a NPV of 83%
(95% CI 80e85%) in men and 78% (95% CI 75e81%) in women.
The NPVs varied from 87% (95% CI 81e92%) in the North
Denmark Region to 72% (95% CI 68e77%) in the Sealand
Region. Among the patients with a diagnosis of pneumonia
without COPD code, 18% (95% CI 16e20%) of the patients
had COPD (NPVZ 82% (95% CI 80e84%)), whereas among
the patients coded with acute respiratory failure without
COPD code, an even higher percentage of 41% (95% CI
32e51%) had COPD (NPVZ 59% (95% CI 49e68%)). When we
stratified the data based on the type of hospital depart-
ment, the NPVs tended to be slightly lower in the special-
ized pulmonary medical departments than in the general
medical departments. The NPV for COPD confirmed with
FEV1/FVC ratio< 70% within the last 3 years was consider-
ably higher at 91% (95% CI 89e92%) overall.
Discussion
The present study is the first nationwide study of the val-
idity of the population-based DNPR with regard to COPD
diagnoses. We found that the positive predictive value of
acute COPD diagnoses in the registry is high. At the same
time, there seems to be a substantial underrecording of
COPD among patients hospitalized with pneumonia and in
particular among patients hospitalized with respiratory
failure.
Table 1 Characteristics of all patients acutely admitted with COPD in Denmark recorded in the DNIP database 2008, and of the
two groups sampled for the validation study: patients admitted with COPD, and patients hospitalized with pneumonia or
respiratory failure without COPD diagnosis.
Characteristic Patients with
COPD in the DNIP
database (nZ 19,672)
Patients with
COPD in the validation
sample (nZ 1988)
Patients without COPD
in the validation sample (nZ 1986)
Median age (quartiles) in years 74 (66e80) 74 (66e81) 75 (62e83)
Sex
Female 10,901 (55%) 1082 (54%) 944 (48%)
Male 8771 (45%) 906 (46%) 1042 (52%)
Charlson comorbidity index score (COPD excluded)
0 7603 (39%) 861 (43%) 1185 (60%)
1 5195 (26%) 476 (24%) 261 (13%)
2 3012 (15%) 270 (14%) 261 (13%)
3þ 3862 (20%) 381 (19%) 279 (14%)
Assisted ventilation during
hospitalization
Non-invasive ventilation 1535 (8%) 124 (6%) a
Ventilator 540 (3%) 32 (2%) a
Cumulative 30-day mortality 1841 (9%) 193 (10%) a
a Data on ventilation and mortality not recorded for non-COPD patient sample.
1066 R.W. Thomsen et al.The strengths of our study included the access to
medical records with detailed clinical data for two entire
nationwide validation cohorts. The large sample size
resulted in an improved statistical precision compared to
previous studies, and made it possible to perform subgroup
analysis. We only received filled data forms for approxi-
mately 80% of the hospitalization episodes, yet this was
largely explained by non-participation of a few specific
hospitals due to logistic difficulties, and we believe that the
patients and the hospitals included in this study are
representative of the Danish hospitals and the DNPR as
a whole. Because the Danish National Health Service
provides free universal tax-supported health care for all
inhabitants, disadvantaged population groups are not
underrepresented in our study, and there are no financial
incentives for hospitals not to not provide a similar diag-
nostic workup for all patients.9
This study also has limitations. Physicians used medical
records as the gold standard when assessing the predictive
value of the diagnoses recorded in the DNPR. Although this
is the conventional approach used in most validation
studies, medical records are not perfect, and it can be
difficult to assess the quality of the information theyTable 2 Positive predictive values of COPD diagnoses for 158
Registry.






COPD, specialized pulmonary medicine department
COPD, general medicine departmentcontain.9,14 The medical records were reviewed by a large
number of different physicians, with the possibility of inter-
observer variation in the evaluations. Furthermore, the
reviewers were not blinded to the diagnosis codes, since
presence or absence of the COPD register diagnosis was by
definition given for all the examined patients in the two
groups. Thus, knowledge of the COPD diagnosis code could
have influenced the results of the physicians’ assessment.
COPD is a complex disease characterized by chronic, not
fully reversible airflow limitation, a range of pathological
changes in the lung, significant extrapulmonary effects,
and frequent comorbidities.1 The characteristic symptoms
of COPD are chronic and progressive dyspnea, cough, and
sputum production. According to the GOLD criteria, an
accurate COPD diagnosis requires spirometry.1,2 However,
in real-world clinical practice in acutely hospitalized COPD
patients, an updated spirometry result is often not avail-
able in the hospital record. Thus, in recent audits of
hospitalizations for COPD in Norway/Sweden and the UK,
respectively, 19% and 47% of COPD patients had no acces-
sible spirometry data before or during admission.14,15
Therefore, in our study we pragmatically defined COPD as
presence of a medical history of COPD together with clinical1 acutely admitted patients in the Danish National Patient
n COPD verified PPV (95% CI)
1581 1456 92 (91e93)
1223 1143 93 (92e95)
358 313 87 (84e91)
737 680 92 (90e94)
844 776 92 (90e94)
279 265 95 (92e97)
1292 1185 92 (90e93)
Table 3 Negative predictive values of absence of COPD diagnoses for 1546 patients acutely admitted with pneumonia or acute
respiratory failure discharge diagnoses in the Danish National Patient Registry.
Discharge diagnoses in the Danish National Patient Registry n COPD verified NPV (95% CI)
Pneumonia or acute respiratory failure 1546 300 81 (79e83)
Pneumonia 1432 253 82 (80e84)
Acute respiratory failure 114 47 59 (49e68)
Pneumonia or acute respiratory failure, men 830 144 83 (80e85)
Pneumonia or acute respiratory failure, women 716 156 78 (75e81)
Pneumonia or acute respiratory failure, specialized pulmonary medicine department 145 39 73 (65e80)
Pneumonia or acute respiratory failure, general medicine department 1344 253 81 (79e83)
Validity and underrecording of COPD diagnosis in Denmark 1067symptoms and signs of COPD, supported by presence of
a spirometry with FEV1/FVC ratio< 70% within the last three
years, if available. This definition is open to some subjective
interpretation of symptoms and signs by the reviewing
physicians. Itmaybeconsidereda limitation of our validation
study that physicians were not asked for date and result of
the most recent FEV1/FVC measurement for each patient
regardless of the measured value. Thus, we do not know the
exact reasons behind the fact that 39% of the reviewed
patients had no recent spirometrywith FEV1/FVC ratio< 70%
recorded. Different scenarios are possible, i.e.; the patients
had not been examined with spirometry at all, patients did
have spirometry performed in another clinical setting with
results unavailable for the reviewing physician, patients did
have a spirometry with FEV1/FVC ratio< 70% performed
more than 3 years ago, or patients did have a recent
spirometry with FEV1/FVC ratio> 70% suggesting another
diagnosis than COPD. Based on clinical experience in our
setting and on thewritten comments we received frommany
clinicians involved in the validation study, for example: “This
patient has his lung function parameters controlled in
another outpatient clinic” or “This patient is normally fol-
lowed in another hospital for his COPD and was only here for
intensive care”, etc., we find it likely that simple unavail-
ability of any updated spirometry results in the reviewed
hospital record constitute the vast majority of cases where
COPD was defined on the basis of clinical history.
In our literature search, we were unable to find valida-
tion studies similar to ours in order to compare our present
findings with earlier results. Previous studies focusing on
underdiagnosing and underreporting of COPD comprise
either cohorts of the general population,11,16 patients in
general practice17 or patients with heart disease.18 In
particular, there has been focus on COPD diagnostic prob-
lems among patients with heart failure,19 but no studies on
underreporting of COPD among patients with pneumonia or
respiratory failure, although COPD is an important risk
factor for both conditions.20
It is reassuring that the diagnosis of COPD in acutely
admitted patients has high validity when assessed through
clinical criteria by experienced physicians. We observed
higher validity of the COPD diagnosis given in specialized
pulmonary than general medical departments, as we would
expect in a specialist setting. At the same time and more
unexpected, NPVs for COPD tended to be lower in the
specialist setting, corresponding to more false negative
COPD patients in pulmonary than general medical depart-
ments. This fact may have to do with a more frequent andcorrect use of pneumonia and acute respiratory failure as
primary diagnostic codes in pulmonary medical depart-
ments, with potential simultaneous underregistration of
COPD as secondary diagnosis during the same episode.
The implications of problems relating to the data quality
of registry-based COPD discharge codes differ between
different purposes and study designs.5,6 Thus, in studies of
the incidence of acute hospitalizations with COPD, use of
codes J44 without further validation would only over-
estimate the COPD incidence slightly per se, since the
codes are highly valid. In contrary, exclusive use of J44
codes may lead to substantial underestimation of acute
COPD hospitalization incidences, since there seems to be
substantial underrecording of COPD during hospitalizations
with other acute respiratory disorders. Furthermore, some
patients with true COPD may have been wrongly coded with
codes that we did not examine, including J42 (unspecified
chronic bronchitis) or J43 (emphysema), potentially leading
to further underestimation of acute COPD hospitalization
incidences.4 In analytical epidemiological studies, the
misclassification of COPD diagnoses would tend to bias the
examined associations toward the null hypothesis, as long
as the COPD sensitivity and specificity is not strongly asso-
ciated with exposure. Importantly, in analytic database
studies investigators would usually aim to screen the
patients’ entire previous hospitalization history for COPD
diagnosis codes, likely leading to increased completeness of
COPD exposure as compared to assessment from a single
hospitalization episode only. For health care quality
measurement such as the DNIP, the rather similar COPD
data quality in Danish regions suggests that quality of care
indicator results can be validly compared between regions.
Conclusion
In conclusion, we found a high predictive value (>90%) of
the diagnosis of COPD for acutely admitted patients when
we used clinical COPD criteria with or without spirometry.
At the same time, there is a substantial underrecording of
COPD during hospitalizations with other acute respiratory
disorders, like pneumonia or respiratory failure, which may
lead to substantial underestimation of the incidence of
acute admissions with COPD on the population level.
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